Zolgensma (onasemnogene abeparvovec-xioi)

spinraza

Pharma

Biogen reports promising results for higher dose of Spinraza

A trial of Biogen’s spinal muscular atrophy therapy Spinraza suggests that a higher dose provides benefits to a broad range of patients.

Kevin Dunleavy Oct 9, 2024 7:30am

spinraza

Biogen to seek approval for high-dose version of Spinraza

Sep 4, 2024 11:45am

Genentech backs song recording by and for SMA community

Genentech SMA song 'Spaces' played at Special Olympics close

Jun 14, 2022 5:52am